The Use of Weight-of-evidence Approaches to Characterize Developmental Toxicity Risk for Therapeutic Monoclonal Antibodies in Humans Without in Vivo Studies.
Regulatory Toxicology and Pharmacology（2024）
Key words
Developmental and reproductive toxicity,Monoclonal antibodies,In vivo studies,Nonclinical,Regulatory,Weight-of-evidence approach,3Rs
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined